Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group

BACKGROUND: The palliative role of chemoradiation in the treatment of patients with locally advanced, inoperable non-small-cell lung cancer stage III and negative prognostic factors remains unresolved. METHODS: Patients not eligible for curative radiotherapy were randomised to receive either chemora...

Descripción completa

Detalles Bibliográficos
Autores principales: Strøm, H H, Bremnes, R M, Sundstrøm, S H, Helbekkmo, N, Fløtten, Ø, Aasebø, U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776981/
https://www.ncbi.nlm.nih.gov/pubmed/23963145
http://dx.doi.org/10.1038/bjc.2013.466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776981/
https://www.ncbi.nlm.nih.gov/pubmed/23963145
http://dx.doi.org/10.1038/bjc.2013.466

Ejemplares similares